329 related articles for article (PubMed ID: 18390664)
1. Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis.
Gelber SE; Aguilar JL; Lewis KL; Ratner AJ
J Bacteriol; 2008 Jun; 190(11):3896-903. PubMed ID: 18390664
[TBL] [Abstract][Full Text] [Related]
2. Vaginolysin drives epithelial ultrastructural responses to Gardnerella vaginalis.
Randis TM; Zaklama J; LaRocca TJ; Los FC; Lewis EL; Desai P; Rampersaud R; Amaral FE; Ratner AJ
Infect Immun; 2013 Dec; 81(12):4544-50. PubMed ID: 24082080
[TBL] [Abstract][Full Text] [Related]
3. Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin.
Randis TM; Kulkarni R; Aguilar JL; Ratner AJ
PLoS One; 2009; 4(4):e5207. PubMed ID: 19370149
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Gardnerella vaginalis and Vaginolysin with the Apical versus Basolateral Face of a Three-Dimensional Model of Vaginal Epithelium.
Garcia EM; Kraskauskiene V; Koblinski JE; Jefferson KK
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30692180
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-Dependent Cytolysins Produced by Vaginal Bacteria: Certainties and Controversies.
Pleckaityte M
Front Cell Infect Microbiol; 2019; 9():452. PubMed ID: 31998661
[TBL] [Abstract][Full Text] [Related]
6. The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59.
Zilnyte M; Venclovas Č; Zvirbliene A; Pleckaityte M
Toxins (Basel); 2015 Jan; 7(1):110-28. PubMed ID: 25590277
[TBL] [Abstract][Full Text] [Related]
7. Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis.
Pleckaityte M; Mistiniene E; Lasickiene R; Zvirblis G; Zvirbliene A
BMC Biotechnol; 2011 Nov; 11():100. PubMed ID: 22047084
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of monoclonal antibodies against vaginolysin: mapping of a region critical for its cytolytic activity.
Zvirbliene A; Pleckaityte M; Lasickiene R; Kucinskaite-Kodze I; Zvirblis G
Toxicon; 2010 Aug; 56(1):19-28. PubMed ID: 20298711
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and vaginolysin in Gardnerella vaginalis from healthy and bacterial vaginosis diagnosed women.
Knupp de Souza DM; Diniz CG; Filho DS; Andrade de Oliveira LM; Coelho DM; Talha LS; Nascimento TC; Ferreira-Machado AB; Silva VL
J Infect Dev Ctries; 2016 Sep; 10(9):913-919. PubMed ID: 27694723
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of cholesterol-dependent vaginolysin into tethered phospholipid bilayers: implications for bioanalysis.
Budvytyte R; Pleckaityte M; Zvirbliene A; Vanderah DJ; Valincius G
PLoS One; 2013; 8(12):e82536. PubMed ID: 24349307
[TBL] [Abstract][Full Text] [Related]
11. Association between statin use, the vaginal microbiome, and Gardnerella vaginalis vaginolysin-mediated cytotoxicity.
Abdelmaksoud AA; Girerd PH; Garcia EM; Brooks JP; Leftwich LM; Sheth NU; Bradley SP; Serrano MG; Fettweis JM; Huang B; Strauss JF; Buck GA; Jefferson KK
PLoS One; 2017; 12(8):e0183765. PubMed ID: 28846702
[TBL] [Abstract][Full Text] [Related]
12. Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners.
Rampersaud R; Planet PJ; Randis TM; Kulkarni R; Aguilar JL; Lehrer RI; Ratner AJ
J Bacteriol; 2011 Mar; 193(5):1034-41. PubMed ID: 21169489
[TBL] [Abstract][Full Text] [Related]
13. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus crispatus represses vaginolysin expression by BV associated Gardnerella vaginalis and reduces cell cytotoxicity.
Castro J; Martins AP; Rodrigues ME; Cerca N
Anaerobe; 2018 Apr; 50():60-63. PubMed ID: 29427630
[TBL] [Abstract][Full Text] [Related]
15. The diversity of receptor recognition in cholesterol-dependent cytolysins.
Tabata A; Ohkura K; Ohkubo Y; Tomoyasu T; Ohkuni H; Whiley RA; Nagamune H
Microbiol Immunol; 2014 Mar; 58(3):155-71. PubMed ID: 24401114
[TBL] [Abstract][Full Text] [Related]
16. Genetic and biochemical diversity of Gardnerella vaginalis strains isolated from women with bacterial vaginosis.
Pleckaityte M; Janulaitiene M; Lasickiene R; Zvirbliene A
FEMS Immunol Med Microbiol; 2012 Jun; 65(1):69-77. PubMed ID: 22309200
[TBL] [Abstract][Full Text] [Related]
17. The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly.
Dowd KJ; Farrand AJ; Tweten RK
PLoS Pathog; 2012; 8(7):e1002787. PubMed ID: 22792065
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential.
Yeoman CJ; Yildirim S; Thomas SM; Durkin AS; Torralba M; Sutton G; Buhay CJ; Ding Y; Dugan-Rocha SP; Muzny DM; Qin X; Gibbs RA; Leigh SR; Stumpf R; White BA; Highlander SK; Nelson KE; Wilson BA
PLoS One; 2010 Aug; 5(8):e12411. PubMed ID: 20865041
[TBL] [Abstract][Full Text] [Related]
19. Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies.
Harwich MD; Alves JM; Buck GA; Strauss JF; Patterson JL; Oki AT; Girerd PH; Jefferson KK
BMC Genomics; 2010 Jun; 11():375. PubMed ID: 20540756
[TBL] [Abstract][Full Text] [Related]
20. Sequence Comparison of Vaginolysin from Different
Garcia EM; Serrano MG; Edupuganti L; Edwards DJ; Buck GA; Jefferson KK
Pathogens; 2021 Jan; 10(2):. PubMed ID: 33498226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
